A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

Condition:   Gastric or Gastroesophageal Junction(GEJ) Adenocarcinoma Intervention:   Drug: Trastuzumab, Capecitabine and Cisplatin Sponsor:   Asan Medical Center Not yet recruiting

Source: ClinicalTrials.gov - March 16, 2020 Category: Research Source Type: clinical trials